AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
116 hedge funds and large institutions have $589M invested in Accelerate Diagnostics in 2018 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 33 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
55% less call options, than puts
Call options by funds: $6.54M | Put options by funds: $14.7M
Holders
116
Holding in Top 10
4
Calls
$6.54M
Puts
$14.7M
Top Buyers
1 | +$39.7M | |
2 | +$5.1M | |
3 | +$4.6M | |
4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$4.28M |
5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.05M |
Top Sellers
1 | -$9.97M | |
2 | -$8.88M | |
3 | -$6.7M | |
4 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
-$6.47M |
5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$6.28M |